35.285 USD
-0.15 (-0.41%)
Overall IBEX gets a fundamental rating of 7 out of 10. We evaluated IBEX against 85 industry peers in the IT Services industry. IBEX gets an excellent profitability rating and is at the same time showing great financial health properties. An interesting combination arises when we look at growth and value: IBEX is growing strongly while it also seems undervalued. These ratings would make IBEX suitable for value and growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year IBEX was profitable.
IBEX had a positive operating cash flow in the past year.
In the past 5 years IBEX has always been profitable.
IBEX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
IBEX has a better Return On Assets (13.49%) than 92.94% of its industry peers.
IBEX's Return On Equity of 27.45% is amongst the best of the industry. IBEX outperforms 89.41% of its industry peers.
Looking at the Return On Invested Capital, with a value of 20.43%, IBEX belongs to the top of the industry, outperforming 94.12% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.49% | ||
| ROE | 27.45% | ||
| ROIC | 20.43% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Profit Margin value of 6.60%, IBEX is doing good in the industry, outperforming 68.24% of the companies in the same industry.
IBEX's Profit Margin has improved in the last couple of years.
IBEX's Operating Margin of 8.71% is fine compared to the rest of the industry. IBEX outperforms 65.88% of its industry peers.
IBEX's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 30.91%, IBEX is in line with its industry, outperforming 43.53% of the companies in the same industry.
In the last couple of years the Gross Margin of IBEX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.71% | ||
| PM (TTM) | 6.6% | ||
| GM | 30.91% |
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
2. Health
2.1 Basic Checks
IBEX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
There is no outstanding debt for IBEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
IBEX has an Altman-Z score of 5.11. This indicates that IBEX is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 5.11, IBEX is doing good in the industry, outperforming 75.29% of the companies in the same industry.
The Debt to FCF ratio of IBEX is 0.06, which is an excellent value as it means it would take IBEX, only 0.06 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.06, IBEX belongs to the best of the industry, outperforming 90.59% of the companies in the same industry.
IBEX has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
IBEX has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. IBEX outperforms 81.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.06 | ||
| Altman-Z | 5.11 |
ROIC/WACC2.27
WACC8.99%
2.3 Liquidity
A Current Ratio of 1.82 indicates that IBEX should not have too much problems paying its short term obligations.
With a Current ratio value of 1.82, IBEX perfoms like the industry average, outperforming 56.47% of the companies in the same industry.
IBEX has a Quick Ratio of 1.82. This is a normal value and indicates that IBEX is financially healthy and should not expect problems in meeting its short term obligations.
IBEX has a Quick ratio of 1.82. This is comparable to the rest of the industry: IBEX outperforms 56.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.82 |
3. Growth
3.1 Past
IBEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.96%, which is quite impressive.
IBEX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 41.04% yearly.
The Revenue has grown by 9.77% in the past year. This is quite good.
Measured over the past years, IBEX shows a small growth in Revenue. The Revenue has been growing by 6.62% on average per year.
EPS 1Y (TTM)41.96%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%73.08%
Revenue 1Y (TTM)9.77%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%16.55%
3.2 Future
The Earnings Per Share is expected to grow by 12.11% on average over the next years. This is quite good.
Based on estimates for the next years, IBEX will show a quite strong growth in Revenue. The Revenue will grow by 8.28% on average per year.
EPS Next Y16.57%
EPS Next 2Y12.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.8%
Revenue Next 2Y8.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 11.10, the valuation of IBEX can be described as very reasonable.
87.06% of the companies in the same industry are more expensive than IBEX, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.37, IBEX is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 10.03, the valuation of IBEX can be described as reasonable.
Based on the Price/Forward Earnings ratio, IBEX is valued cheaper than 89.41% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.20, IBEX is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.1 | ||
| Fwd PE | 10.03 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IBEX is valued cheaply inside the industry as 87.06% of the companies are valued more expensively.
64.71% of the companies in the same industry are more expensive than IBEX, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.41 | ||
| EV/EBITDA | 7.04 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of IBEX may justify a higher PE ratio.
A more expensive valuation may be justified as IBEX's earnings are expected to grow with 12.11% in the coming years.
PEG (NY)0.67
PEG (5Y)0.27
EPS Next 2Y12.11%
EPS Next 3YN/A
5. Dividend
5.1 Amount
IBEX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:IBEX (12/4/2025, 10:39:47 AM)
35.285
-0.15 (-0.41%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners94.9%
Inst Owner Change-3.89%
Ins Owners8.95%
Ins Owner Change-3.25%
Market Cap475.29M
Revenue(TTM)558.27M
Net Income(TTM)36.86M
Analysts45.71
Price Target39.27 (11.29%)
Short Float %1.11%
Short Ratio1.31
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.37%
Min EPS beat(2)10.89%
Max EPS beat(2)21.85%
EPS beat(4)4
Avg EPS beat(4)13.65%
Min EPS beat(4)7.33%
Max EPS beat(4)21.85%
EPS beat(8)7
Avg EPS beat(8)11.1%
EPS beat(12)10
Avg EPS beat(12)14.9%
EPS beat(16)11
Avg EPS beat(16)6.92%
Revenue beat(2)2
Avg Revenue beat(2)6.82%
Min Revenue beat(2)5.12%
Max Revenue beat(2)8.52%
Revenue beat(4)4
Avg Revenue beat(4)4.42%
Min Revenue beat(4)1.58%
Max Revenue beat(4)8.52%
Revenue beat(8)4
Avg Revenue beat(8)1.31%
Revenue beat(12)4
Avg Revenue beat(12)-0.58%
Revenue beat(16)6
Avg Revenue beat(16)-0.56%
PT rev (1m)0%
PT rev (3m)26.23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)18.55%
EPS NY rev (1m)0%
EPS NY rev (3m)4.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.66%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.1 | ||
| Fwd PE | 10.03 | ||
| P/S | 0.85 | ||
| P/FCF | 17.41 | ||
| P/OCF | 10.41 | ||
| P/B | 3.54 | ||
| P/tB | 3.89 | ||
| EV/EBITDA | 7.04 |
EPS(TTM)3.18
EY9.01%
EPS(NY)3.52
Fwd EY9.97%
FCF(TTM)2.03
FCFY5.74%
OCF(TTM)3.39
OCFY9.61%
SpS41.45
BVpS9.97
TBVpS9.06
PEG (NY)0.67
PEG (5Y)0.27
Graham Number26.71
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.49% | ||
| ROE | 27.45% | ||
| ROCE | 25.17% | ||
| ROIC | 20.43% | ||
| ROICexc | 22.19% | ||
| ROICexgc | 23.83% | ||
| OM | 8.71% | ||
| PM (TTM) | 6.6% | ||
| GM | 30.91% | ||
| FCFM | 4.89% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
F-Score8
Asset Turnover2.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.06 | ||
| Debt/EBITDA | 0.01 | ||
| Cap/Depr | 106.63% | ||
| Cap/Sales | 3.29% | ||
| Interest Coverage | 29.77 | ||
| Cash Conversion | 69.33% | ||
| Profit Quality | 74.04% | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.82 | ||
| Altman-Z | 5.11 |
F-Score8
WACC8.99%
ROIC/WACC2.27
Cap/Depr(3y)83.97%
Cap/Depr(5y)108.52%
Cap/Sales(3y)2.89%
Cap/Sales(5y)3.72%
Profit Quality(3y)75.63%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.96%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%73.08%
EPS Next Y16.57%
EPS Next 2Y12.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.77%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%16.55%
Revenue Next Year10.8%
Revenue Next 2Y8.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.91%
EBIT growth 3Y33.16%
EBIT growth 5Y20.06%
EBIT Next Year66.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.92%
FCF growth 3Y24.66%
FCF growth 5Y-10.09%
OCF growth 1Y27.21%
OCF growth 3Y4.51%
OCF growth 5Y-2.46%
IBEX LTD / IBEX FAQ
Can you provide the ChartMill fundamental rating for IBEX LTD?
ChartMill assigns a fundamental rating of 7 / 10 to IBEX.
Can you provide the valuation status for IBEX LTD?
ChartMill assigns a valuation rating of 8 / 10 to IBEX LTD (IBEX). This can be considered as Undervalued.
What is the profitability of IBEX stock?
IBEX LTD (IBEX) has a profitability rating of 7 / 10.
Can you provide the financial health for IBEX stock?
The financial health rating of IBEX LTD (IBEX) is 7 / 10.
Can you provide the expected EPS growth for IBEX stock?
The Earnings per Share (EPS) of IBEX LTD (IBEX) is expected to grow by 16.57% in the next year.